Skip to main content

Advertisement

SpringerLink
Log in

Bone mineral density and risk of breast cancer in postmenopausal women

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

High bone mineral density (BMD) has been associated with increased breast cancer in prospective studies of postmenopausal women, but the real relationship is still controversial. Therefore, we undertook a meta-analysis to evaluate the association between BMD and the risk of breast cancer in postmenopausal women. We performed systematic searches on MEDLINE, EMBASE, and OVID. Data extraction was performed independently by two reviewers. For each study, we extracted the relative risks (RRs) and 95 % confidence intervals (CIs) for categorical variables and per standard deviation (SD) increases in BMD. Heterogeneity, publication bias, and subgroup analysis were performed. The analysis included 70,878 postmenopausal women from 10 studies with 1,889 breast cancers during a mean follow-up of 6 years (range 3.2–8.4 years). The summary RRs for the highest versus lowest categorical variable showed that higher BMD in the hip (RR 1.62; 95 % CI: 1.17–2.06) and in the spine (RR 1.82; 95 % CI: 1.07–2.57) were associated with a 62 and 82 % increased risk of breast cancer. Per SD, increase in hip BMD and spine BMD were also associated with a higher risk of breast cancer (RR for hip BMD 1.20; 95 % CI: 1.09–1.31 and RR for spine BMD 1.26; 95 % CI: 1.10–1.41). In this meta-analysis, a higher BMD was found to be associated with a significantly higher risk of breast cancer in postmenopausal women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wildiers H, Kunkler I, Biganzoli L, Fracheboud J, Vlastos G, Bernard-Marty C, Hurria A, Extermann M, Girre V, Brain E, Audisio RA, Bartelink H, Barton M, Giordano SH, Muss H, Aapro M (2007) Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 8(12):1101–1115

    Article  PubMed  Google Scholar 

  2. Galus M (1997) Osteoporosis and mortality. Ann Intern Med 127(11):1040

    PubMed  CAS  Google Scholar 

  3. Ribot C, Pouilles JM, Bonneu M, Tremollieres F (1992) Assessment of the risk of post-menopausal osteoporosis using clinical factors. Clin Endocrinol (Oxf) 36(3):225–228

    Article  CAS  Google Scholar 

  4. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB (2003) Effects of estrogen plus progestin on risk of fracture and bone mineral density: the women’s health initiative randomized trial. JAMA 290(13):1729–1738

    Article  PubMed  CAS  Google Scholar 

  5. Castiglione-Gertsch M (2004) Hormone replacement and breast cancer. Ann Oncol 15(Suppl 4):275–277

    Google Scholar 

  6. Clavel-Chapelon F, Gerber M (2002) Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis? Breast Cancer Res Treat 72(2):107–115

    Article  PubMed  CAS  Google Scholar 

  7. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286(22):2815–2822

    Article  PubMed  CAS  Google Scholar 

  8. Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD, Berkelman RL (1991) A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265(15):1985–1990

    Article  PubMed  CAS  Google Scholar 

  9. Kerlikowske K, Shepherd J, Creasman J, Tice JA, Ziv E, Cummings SR (2005) Are breast density and bone mineral density independent risk factors for breast cancer? J Natl Cancer Inst 97(5):368–374

    Article  PubMed  Google Scholar 

  10. Zmuda JM, Cauley JA, Ljung BM, Bauer DC, Cummings SR, Kuller LH (2001) Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst 93(12):930–936

    Article  PubMed  CAS  Google Scholar 

  11. Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR (1996) Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 276(17):1404–1408

    Article  PubMed  CAS  Google Scholar 

  12. Tremollieres F, Ribot C (2010) Bone mineral density and prediction of non-osteoporotic disease. Maturitas 65(4):348–351

    Article  PubMed  Google Scholar 

  13. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Group. JAMA 283(15):2008–2012

    Article  PubMed  CAS  Google Scholar 

  14. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269

    PubMed  Google Scholar 

  15. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457

    Article  Google Scholar 

  16. Zhang J, Yu KF (1998) What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280(19):1690–1691

    Article  PubMed  CAS  Google Scholar 

  17. McNutt LA, Wu C, Xue X, Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157(10):940–943

    Article  PubMed  Google Scholar 

  18. Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301–1309

    PubMed  CAS  Google Scholar 

  19. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  PubMed  CAS  Google Scholar 

  20. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560

    Article  PubMed  Google Scholar 

  21. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558

    Article  PubMed  Google Scholar 

  22. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  PubMed  CAS  Google Scholar 

  23. Nguyen TV, Center JR, Eisman JA (2000) Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study. Maturitas 36(1):27–34

    Article  PubMed  CAS  Google Scholar 

  24. Buist DS, LaCroix AZ, Barlow WE, White E, Weiss NS (2001) Bone mineral density and breast cancer risk in postmenopausal women. J Clin Epidemiol 54(4):417–422

    Article  PubMed  CAS  Google Scholar 

  25. Ganry O, Tramier B, Fardellone P, Raverdy N, Dubreuil A (2001) High bone-mass density as a marker for breast cancer in post-menopausal women. Breast 10(4):313–317

    Article  PubMed  CAS  Google Scholar 

  26. van der Klift M, de Laet CE, Coebergh JW, Hofman A, Pols HA (2003) Bone mineral density and the risk of breast cancer: the Rotterdam Study. Bone 32(3):211–216

    Article  PubMed  Google Scholar 

  27. Ganry O, Baudoin C, Fardellone P, Peng J, Raverdy N (2004) Bone mass density and risk of breast cancer and survival in older women. Eur J Epidemiol 19(8):785–792

    Article  PubMed  CAS  Google Scholar 

  28. Cauley JA, Song J, Dowsett SA, Mershon JL, Cummings SR (2007) Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors. Breast Cancer Res Treat 102(2):181–188

    Article  PubMed  Google Scholar 

  29. Chen Z, Arendell L, Aickin M, Cauley J, Lewis CE, Chlebowski R (2008) Hip bone density predicts breast cancer risk independently of Gail score: results from the women’s health initiative. Cancer 113(5):907–915

    Article  PubMed  Google Scholar 

  30. Grenier D, Cooke AL, Lix L, Metge C, Lu H, Leslie WD (2011) Bone mineral density and risk of postmenopausal breast cancer. Breast Cancer Res Treat 126(3):679–686

    Article  PubMed  Google Scholar 

  31. Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR (1999) Continuing screening mammography in women aged 70–79 years: impact on life expectancy and cost-effectiveness. JAMA 282(22):2156–2163

    Article  PubMed  CAS  Google Scholar 

  32. Cauley JA, Gutai JP, Sandler RB, LaPorte RE, Kuller LH, Sashin D (1986) The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women. Am J Epidemiol 124(5):752–761

    PubMed  CAS  Google Scholar 

  33. Greendale GA, Edelstein S, Barrett-Connor E (1997) Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res 12(11):1833–1843

    Article  PubMed  CAS  Google Scholar 

  34. Qiu J, Yang R, Rao Y, Du Y, Kalembo FW (2012) Risk factors for breast cancer and expression of insulin-like growth factor-2 (IGF-2) in women with breast cancer in Wuhan city, China. PLoS One 7(5):e36497

    Article  PubMed  CAS  Google Scholar 

  35. Key TJ, Appleby PN, Reeves GK, Roddam AW (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11(6):530–542

    Article  PubMed  Google Scholar 

  36. Adami S, Zivelonghi A, Braga V, Fracassi E, Gatti D, Rossini M, Ulivieri FM, Viapiana O (2010) Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. Bone 46(1):244–247

    Article  PubMed  CAS  Google Scholar 

  37. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD (2009) Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101(1):48–60

    Article  PubMed  CAS  Google Scholar 

  38. Malpe R, Baylink DJ, Linkhart TA, Wergedal JE, Mohan S (1997) Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent. J Bone Miner Res 12(3):423–430

    Article  PubMed  CAS  Google Scholar 

  39. Grainger DJ, Percival J, Chiano M, Spector TD (1999) The role of serum TGF-beta isoforms as potential markers of osteoporosis. Osteoporos Int 9(5):398–404

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

K. Dai and Y. Hao were supported by the Fund for Key National Basic Research Program of China (Grant No. 2012CB619101), Major Basic Research of Science and Technology Commission of Shanghai Municipality (Grant No. 11DJ1400303), and Key Disciplines of Shanghai Municipal Education Commission (Grant No. J50206). The funding sources had no role in the study design, collection, analysis, or interpretation of data, or writing of the report. The authors report that they have no relationships with industry to disclose.

Conflict of interest

The authors have nothing to disclose.

Author information

Authors and Affiliations

  1. Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedics, Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, 639 Zhizaoju Road, Shanghai, 200011, China

    Xinhua Qu, An Qin, Guangwang Liu, Zanjing Zhai, Yongqiang Hao, Huiwu Li, Zhenan Zhu & Kerong Dai

  2. Department of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, China

    Xiaoyu Zhang

  3. Centre for Orthopaedic Research, School of Surgery, The University of Western Australia, Crawley, WA, Australia

    An Qin

  4. Department of Orthopaedic Surgery, The Central Hospital of Xuzhou, Affiliated Hospital of Medical College of Southeast University, Xuzhou, China

    Guangwang Liu

Authors
  1. Xinhua Qu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaoyu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. An Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guangwang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zanjing Zhai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yongqiang Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Huiwu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zhenan Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kerong Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kerong Dai.

Additional information

Xinhua Qu, Xiaoyu Zhang and An Qin contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qu, X., Zhang, X., Qin, A. et al. Bone mineral density and risk of breast cancer in postmenopausal women. Breast Cancer Res Treat 138, 261–271 (2013). https://doi.org/10.1007/s10549-013-2431-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-013-2431-3

Keywords

Search

Navigation